Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research




News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971
John.lezcano@informa.com
pharmaintelligence.informa.com

Lord O’Neill Blames Governments And Pharma For Faltering AMR Progress

Wed, 10/09/2019 - 7:23am

Three Years After completion of his high-profile AMR Review, Jim O’Neill warns that global progress on antimicrobial resistance has slowed...

      Related Stories 

Mixed Data For Merck KGaA's Disease-Modifying OA Drug

Wed, 10/09/2019 - 7:02am

Sprifermin could be the first drug to affect the underlying disease process in osteoarthritis but data show no significant improvement...

      Related Stories 

Mixed Data For Merck KGaA 's Disease-Modifying OA Drug

Wed, 10/09/2019 - 7:02am

Sprifermin could be the first drug to affect the underlying disease process in osteoarthritis but data show no significant improvement...

      Related Stories 

Audentes' Gene Therapy Allows Ventilator Independence For Rare Disease

Wed, 10/09/2019 - 6:51am

Audentes Therapeutics is aiming for regulatory submissions next year for its lead product, a skeletal muscle-targeted gene therapy, which continues...

      Related Stories 

Culture Change At GSK: “We’re Doing What We Said We’d Do”

Wed, 10/09/2019 - 1:58am

Chief scientific offficer Hal Barron talks about winning hearts and minds of 10,000 R&D employees, and adopting practices of acquisition...

      Related Stories 

Progress Being Made With Cell And Gene Therapy Market Access, But Challenges Remain

Tue, 10/08/2019 - 4:20pm

Drug developers and payers are coming together long before product approvals to work out payment options for high-cost, high-impact cell...

      Related Stories 

Drugs With ‘Unsupported Price Increases’ Add $5bn To US Spending – ICER

Tue, 10/08/2019 - 2:53pm

Pharmaceutical Research and Manufacturers of America describes report as “flawed” and designed to advance the “false narrative that spending on...

      Related Stories 

Hypoxia Nobel Prize Winners: How Biopharma Is Using Their Research

Tue, 10/08/2019 - 12:22pm

Academic research has once again demonstrated itself to the oxygen of inspiration for industry drug innovation, including a blockbuster-in-waiting

      Related Stories 

Label Battles: Beovu and Eylea Contest Begins In AMD

Tue, 10/08/2019 - 10:07am

Shares in Eylea-maker Regeneron slid after FDA approved Novartis's competing VEGF inhibitor for treating AMD, but some observers said investors...

      Related Stories 

Interview: An EU Plan To Pair Pharma With Life Science VCs

Tue, 10/08/2019 - 9:15am

Jan-Philipp Beck, CEO of EIT Health, believes a link-up with the European Investment Fund can only benefit the continent's biotech...

      Related Stories 

New UK Biotech MiroBio Raises $34m For Autoimmune Disease Research

Tue, 10/08/2019 - 12:39am

Company is keeping its cards close to chest on exact mechanism as it enters increasingly competitive autoimmune disease field.

      Related Stories 

'Buy China' In Procurement Schemes - Should You Worry?

Mon, 10/07/2019 - 7:27pm

A recent trade group report points to a rising and alarming "Buy China" trend in procurement rounds in the country...

      Related Stories 

Early Indian Promise For A Cut-Price CAR-T Therapy

Mon, 10/07/2019 - 6:04pm

A faculty member at the Indian Institute of Technology and the founder of Indian venture ImmunoACT hopes to deliver an...

      Related Stories 

Summit Looking To Secure Superiority Claim For Ridinilazole Over Vancomycin In C. Diff

Mon, 10/07/2019 - 2:16pm

Company’s Phase III program is attempting to replicate Phase II efficacy data showing superiority for curing Clostridium difficile infections and...

      Related Stories 

Pfizer Reaffirms CV Disease Commitment With Deal For Akcea's ANGPTL3 Drug

Mon, 10/07/2019 - 1:25pm

Pfizer agreed to pay $250m up front for worldwide rights to a Phase II drug that could target a broad...

      Related Stories 

Ex Shire CEO Ornskov Resurfaces To Lead Skin Group Galderma

Mon, 10/07/2019 - 7:57am

A group of investors has bought Nestlé Skin Health, renamed it Galderma to capitalize on its legacy in dermatology and...

      Related Stories 

J&J Pledges $500m To Eliminate HIV and TB

Mon, 10/07/2019 - 7:10am

The healthcare giant is investing heavily into partnerships designed to beat the two infectious diseases.

      Related Stories 

Pipeline Watch: Anticancers Take Center Stage

Mon, 10/07/2019 - 5:57am

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...

      Related Stories 

Pages